Sana Biotechnology, Inc.

NASDAQ:SANA

5.04 (USD) • At close September 6, 2024
Bedrijfsnaam Sana Biotechnology, Inc.
Symbool SANA
Munteenheid USD
Prijs 5.04
Beurswaarde 1,121,228,640
Dividendpercentage 0%
52-weken bereik 2.745 - 12
Industrie Biotechnology
Sector Healthcare
CEO Dr. Steven D. Harr M.D.
Website https://www.sana.com

An error occurred while fetching data.

Over Sana Biotechnology, Inc.

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others. Its product candidates include SG295

Vergelijkbare Aandelen

Mirum Pharmaceuticals, Inc. logo

Mirum Pharmaceuticals, Inc.

MIRM

41.12 USD

Enanta Pharmaceuticals, Inc. logo

Enanta Pharmaceuticals, Inc.

ENTA

11.54 USD

Syndax Pharmaceuticals, Inc. logo

Syndax Pharmaceuticals, Inc.

SNDX

19.1 USD

Keros Therapeutics, Inc. logo

Keros Therapeutics, Inc.

KROS

52.51 USD

Aclaris Therapeutics, Inc. logo

Aclaris Therapeutics, Inc.

ACRS

1.17 USD

REGENXBIO Inc. logo

REGENXBIO Inc.

RGNX

11.48 USD

National Research Corporation logo

National Research Corporation

NRC

21.71 USD

Kura Oncology, Inc. logo

Kura Oncology, Inc.

KURA

19.29 USD

FibroGen, Inc. logo

FibroGen, Inc.

FGEN

0.39 USD

Financiële Gegevens

Cijfers zijn in miljoenen (USD)

Cijfers zijn in miljoenen (USD)